antibody therapy

Novartis Acquires Immunology Specialist in $425M Deal

📰 Novartis AG to buy immunology specialist Calypso Biotech BV for $425 million. 💉 Acquisition includes potential autoimmune treatment CALY-002. 🧪 Exciting developments in celiac disease and eosinophilic esophagitis research.